A7856

Acipimox

≥99% (TLC)

• Synonim(y): 2-Carboxy-5-methylpyrazine 4-oxide, 5-Methylpyrazinecarboxylic acid 4-oxide
• Wzór empiryczny (zapis Hilla): C₆H₆N₂O₃
• Numer CAS: 51037-30-0
• Masa cząsteczkowa: 154.12
• MDL number: MFCD09033173
• UNSPSC Code: 12352205
• EC Number: 256-928-3
• NACRES: NA.79

Właściwości

• assay: ≥99% (TLC)
• form: powder
• color: off-white to faint yellow
• mp: 177-180 °C
• storage temp.: 2-8°C
• SMILES string: [n+]1(c(cncc1C(=O)O)C)[O-]
• InChI: 1S/C6H6N2O3/c1-4-2-7-3-5(6(9)10)8(4)11/h2-3H,1H3,(H,9,10)
• InChI key: DNRXJHATQULEHC-UHFFFAOYSA-N

Opis

Biochem/physiol Actions

Niacin-derived, vasodilator studied for its lipid-lowering effect.

Acipimox, also known as olbemox, is a nicotinic acid analog. It functions as an anti-lipolytic drug and vasodilator. Acipimox may be used in various metabolic studies involving insulin and ghrelin. It lowers total cholesterol and total triglycerides, which helps in the treatment of hyperlipidemia.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Gloves